SGLT2 Inhibitors Show Early Remodeling Benefits in Hypertension With Pre-HF Tags TPHT_others Read more about SGLT2 Inhibitors Show Early Remodeling Benefits in Hypertension With Pre-HF
Can Nicorandil Improve Renal Safety in the Cath Lab? New Meta-analysis Says Yes Tags TPHT_others Read more about Can Nicorandil Improve Renal Safety in the Cath Lab? New Meta-analysis Says Yes
Sacubitril/Valsartan Lowers NT-proBNP More Than Enalapril in Chagas-Associated HFrEF Tags TPHT_others Read more about Sacubitril/Valsartan Lowers NT-proBNP More Than Enalapril in Chagas-Associated HFrEF
Levosimendan Provides No Additional Benefit During VA-ECMO Support Tags TPHT_others Read more about Levosimendan Provides No Additional Benefit During VA-ECMO Support
Across All LVEF Phenotypes, Dapagliflozin Matches Empagliflozin in HF Outcomes Tags TPHT_others Read more about Across All LVEF Phenotypes, Dapagliflozin Matches Empagliflozin in HF Outcomes
AHA 2025 Session: Does Timing of Antihypertensive Therapy Truly Matter for Cardiovascular Risk? Tags TPHT_others Read more about AHA 2025 Session: Does Timing of Antihypertensive Therapy Truly Matter for Cardiovascular Risk?
AHA 2025 Session: Single-Pill Therapy Lowers BP but Not Nocturnal Dipping Tags TPHT_others Read more about AHA 2025 Session: Single-Pill Therapy Lowers BP but Not Nocturnal Dipping
Low-Dose Triple Pill Maintains Blood Pressure Control Over One Year Tags TPHT_others Read more about Low-Dose Triple Pill Maintains Blood Pressure Control Over One Year
Bisoprolol Shows Lower Mortality Than Metoprolol in HFrEF With ESRD Tags TPHT_others Read more about Bisoprolol Shows Lower Mortality Than Metoprolol in HFrEF With ESRD
Discontinuing Beta-Blockers Post-ACS Tied to Higher Death and MI Without Reduction in MACE Tags TPHT_others Read more about Discontinuing Beta-Blockers Post-ACS Tied to Higher Death and MI Without Reduction in MACE